Two-stage Continual Reassessment Method and Patient Heterogeneity for Dose-finding Studies

Ying Kuen Cheung, Dose Finding by the Continual Reassessment Method ,(2011)

Ying Kuen Cheung, On the use of nonparametric curves in phase I trials with low toxicity tolerance. Biometrics. ,vol. 58, pp. 237- 240 ,(2002) , 10.1111/J.0006-341X.2002.00237.X

John O'Quigley, Larry Z. Shen, Anthony Gamst, TWO-SAMPLE CONTINUAL REASSESSMENT METHOD Journal of Biopharmaceutical Statistics. ,vol. 9, pp. 17- 44 ,(1999) , 10.1081/BIP-100100998

Guosheng Yin, Ying Yuan, Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials Journal of the American Statistical Association. ,vol. 104, pp. 954- 968 ,(2009) , 10.1198/JASA.2009.AP08425

Elizabeth Garrett-Mayer, The continual reassessment method for dose-finding studies: a tutorial. Clinical Trials. ,vol. 3, pp. 57- 71 ,(2006) , 10.1191/1740774506CN134OA

Douglas Faries, Practical modifications of the continual reassessment method for phase i cancer clinical trials Journal of Biopharmaceutical Statistics. ,vol. 4, pp. 147- 164 ,(1994) , 10.1080/10543409408835079

Miriam Ayer, H. D. Brunk, G. M. Ewing, W. T. Reid, Edward Silverman, AN EMPIRICAL DISTRIBUTION FUNCTION FOR SAMPLING WITH INCOMPLETE INFORMATION Annals of Mathematical Statistics. ,vol. 26, pp. 641- 647 ,(1955) , 10.1214/AOMS/1177728423

André Rogatko, James S Babb, Hao Wang, Michael J Slifker, Gary R Hudes, None, Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials. Clinical Cancer Research. ,vol. 10, pp. 4645- 4651 ,(2004) , 10.1158/1078-0432.CCR-03-0535

James Babb, André Rogatko, Shelemyahu Zacks, Cancer phase I clinical trials: efficient dose escalation with overdose control Statistics in Medicine. ,vol. 17, pp. 1103- 1120 ,(1998) , 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9

Barry E. Storer, Design and analysis of phase I clinical trials. Biometrics. ,vol. 45, pp. 925- 937 ,(1989) , 10.2307/2531693